Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Volume: 102, Issue: 1, Pages: e8 - e12
Published: Oct 1, 2013
Abstract
Dipeptidyl peptidase-4 inhibitors (DPP-4Is) inhibit the inactivation of incretin hormones while also affecting the immune system, since CD26/DPP-4 is involved in immune regulation. The current study shows that the use of DPP-4Is as therapy for type 2 diabetes patients may induce joint symptoms with decrease in plasma SDF-1α...
Paper Details
Title
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Published Date
Oct 1, 2013
Volume
102
Issue
1
Pages
e8 - e12
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History